• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症中的基因组战争如何应对?

How to approach genome wars in sepsis?

出版信息

Crit Care. 2011;15(6):1007. doi: 10.1186/cc10482. Epub 2011 Dec 2.

DOI:10.1186/cc10482
PMID:22136332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3388672/
Abstract

Sepsis continues to pose a clear challenge as one of the most difficult and costly problems to treat and prevent. Sepsis is caused by systemic or localized infections that damage the integrity of microcirculation in multiple organs. The challenge of sepsis and its long-term sequelae was addressed by the National Institutes of Health National Heart Lung and Blood Institute Division of Blood Diseases and Resources. Defining sepsis as severe endothelial dysfunction syndrome that causes multiorgan failure in response to intravascular or extravascular microbial agents, the National Heart Lung and Blood Institute panel proposed the concept of genome wars as a platform for new diagnostic, therapeutic, and preventive approaches to sepsis.

摘要

败血症仍然是一个极具挑战性且代价高昂的问题,无论是治疗还是预防都存在困难。败血症是由系统性或局部感染引起的,这些感染会损害多个器官的微循环完整性。美国国立卫生研究院国家心肺血液研究所血液疾病和资源分部针对败血症及其长期后遗症提出了应对方案。该方案将败血症定义为严重的内皮功能障碍综合征,这种综合征会导致多器官衰竭,其病因是血管内或血管外微生物制剂。国家心肺血液研究所专家组提出了基因组战争的概念,将其作为败血症新的诊断、治疗和预防方法的平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/3388672/bc13cc4fe03f/cc10482-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/3388672/bc13cc4fe03f/cc10482-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/991c/3388672/bc13cc4fe03f/cc10482-1.jpg

相似文献

1
How to approach genome wars in sepsis?脓毒症中的基因组战争如何应对?
Crit Care. 2011;15(6):1007. doi: 10.1186/cc10482. Epub 2011 Dec 2.
2
New paradigms in sepsis: from prevention to protection of failing microcirculation.脓毒症新范式:从预防到保护衰竭的微循环
J Thromb Haemost. 2015 Oct;13(10):1743-56. doi: 10.1111/jth.13061. Epub 2015 Aug 6.
3
Heartfelt sepsis: microvascular injury due to genomic storm.衷心的败血症:基因组风暴导致的微血管损伤。
Kardiol Pol. 2018;76(8):1203-1216. doi: 10.5603/KP.a2018.0146. Epub 2018 Jul 5.
4
Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis.血管生成素-1变体可减轻脓毒症小鼠模型中脂多糖诱导的微血管功能障碍。
Crit Care. 2012 Oct 4;16(5):R182. doi: 10.1186/cc11666.
5
Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.高渗高渗胶体溶液可改善儿童心脏直视手术后的心脏功能。
Pediatrics. 2006 Jul;118(1):e76-84. doi: 10.1542/peds.2005-2795. Epub 2006 Jun 2.
6
Genomic medicine and lung diseases.基因组医学与肺部疾病。
Am J Respir Crit Care Med. 2012 Aug 1;186(3):280-5. doi: 10.1164/rccm.201203-0569WS. Epub 2012 May 31.
7
Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis.基因组转录谱分析鉴定出败血症伯克霍尔德菌病的候选血液生物标志物特征。
Genome Biol. 2009;10(11):R127. doi: 10.1186/gb-2009-10-11-r127. Epub 2009 Nov 10.
8
Precision medicine for lung diseases: A National Heart, Lung, and Blood Institute perspective.肺部疾病的精准医学:美国国立心肺血液研究所的观点
Ann Allergy Asthma Immunol. 2019 Dec;123(6):537-538. doi: 10.1016/j.anai.2019.07.001. Epub 2019 Jul 4.
9
Paediatric heart failure research: role of the National Heart, Lung, and Blood Institute.儿科心力衰竭研究:国家心肺血液研究所的作用。
Cardiol Young. 2015 Aug;25 Suppl 2:167-71. doi: 10.1017/S1047951115000979.
10
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.

引用本文的文献

1
Activation of thousands of genes in the lungs and kidneys by sepsis is countered by the selective nuclear blockade.脓毒症激活肺部和肾脏中的数千个基因,被选择性核封锁所拮抗。
Front Immunol. 2023 Aug 11;14:1221102. doi: 10.3389/fimmu.2023.1221102. eCollection 2023.
2
Endothelial progenitor cells in the host defense response.宿主防御反应中的内皮祖细胞。
Pharmacol Ther. 2023 Jan;241:108315. doi: 10.1016/j.pharmthera.2022.108315. Epub 2022 Nov 24.
3
Cord Blood Natural Killer Cells Inhibit Sepsis Caused by Feces-Induced Acute Peritonitis via Increasing Endothelium Integrity.

本文引用的文献

1
Broken barriers: a new take on sepsis pathogenesis.打破障碍:脓毒症发病机制的新视角。
Sci Transl Med. 2011 Jun 22;3(88):88ps25. doi: 10.1126/scitranslmed.3002011.
2
The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.阻断白介素 6 在类风湿关节炎之外的价值:当前观点。
Curr Opin Rheumatol. 2011 May;23(3):273-7. doi: 10.1097/BOR.0b013e3283456797.
3
Hospitalizations for extreme conditions mean extreme expenses, study verifies.研究证实,因极端病症住院意味着极高的费用。
脐带血自然杀伤细胞通过增加内皮完整性抑制粪便诱导的急性腹膜炎引起的败血症。
Cell Transplant. 2022 Jan-Dec;31:9636897221090257. doi: 10.1177/09636897221090257.
4
Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis.离散病原体加速宿主抗炎酶的衰老和清除,从而引发败血症。
Cell Host Microbe. 2018 Oct 10;24(4):500-513.e5. doi: 10.1016/j.chom.2018.09.011.
5
Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles.通过靶向核转运穿梭体,多重微生物败血症的生存率、细菌清除率和血小板减少症均得到改善。
PLoS One. 2017 Jun 19;12(6):e0179468. doi: 10.1371/journal.pone.0179468. eCollection 2017.
6
Innate immunity gene expression changes in critically ill patients with sepsis and disease-related malnutrition.脓毒症和疾病相关性营养不良的危重症患者的固有免疫基因表达变化
Cent Eur J Immunol. 2015;40(3):311-24. doi: 10.5114/ceji.2015.54593. Epub 2015 Oct 15.
7
New paradigms in sepsis: from prevention to protection of failing microcirculation.脓毒症新范式:从预防到保护衰竭的微循环
J Thromb Haemost. 2015 Oct;13(10):1743-56. doi: 10.1111/jth.13061. Epub 2015 Aug 6.
8
Experimental acute lung injury induces multi-organ epigenetic modifications in key angiogenic genes implicated in sepsis-associated endothelial dysfunction.实验性急性肺损伤可诱导参与脓毒症相关内皮功能障碍的关键血管生成基因发生多器官表观遗传修饰。
Crit Care. 2015 May 11;19(1):225. doi: 10.1186/s13054-015-0943-4.
9
The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammation.一种核转运调节剂可平息由细菌内毒素引发的“基因组风暴”,该调节剂能减轻局部和全身炎症。
PLoS One. 2014 Oct 20;9(10):e110183. doi: 10.1371/journal.pone.0110183. eCollection 2014.
10
The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.衔接蛋白CRADD/RAIDD通过促炎刺激来控制内皮细胞的激活。
J Biol Chem. 2014 Aug 8;289(32):21973-83. doi: 10.1074/jbc.M114.588723. Epub 2014 Jun 23.
JAMA. 2010 Dec 15;304(23):2579-80. doi: 10.1001/jama.2010.1803.
4
Long-term cognitive impairment and functional disability among survivors of severe sepsis.严重脓毒症幸存者的长期认知障碍和功能残疾。
JAMA. 2010 Oct 27;304(16):1787-94. doi: 10.1001/jama.2010.1553.
5
Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster.《拯救脓毒症运动严重脓毒症和脓毒性休克指南》的实施:我们可以更快推进。
J Crit Care. 2008 Dec;23(4):455-60. doi: 10.1016/j.jcrc.2007.08.003. Epub 2007 Dec 11.
6
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.拯救脓毒症运动:严重脓毒症和脓毒性休克治疗国际指南:2008年版
Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41.
7
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.在开始有效的抗菌治疗之前低血压的持续时间是人类感染性休克生存的关键决定因素。
Crit Care Med. 2006 Jun;34(6):1589-96. doi: 10.1097/01.CCM.0000217961.75225.E9.
8
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.美国严重脓毒症的流行病学:发病率、转归及相关护理费用分析
Crit Care Med. 2001 Jul;29(7):1303-10. doi: 10.1097/00003246-200107000-00002.
9
Efficacy and safety of recombinant human activated protein C for severe sepsis.重组人活化蛋白C治疗严重脓毒症的疗效与安全性
N Engl J Med. 2001 Mar 8;344(10):699-709. doi: 10.1056/NEJM200103083441001.
10
Clinical trials for severe sepsis. Past failures, and future hopes.严重脓毒症的临床试验。过去的失败与未来的希望。
Infect Dis Clin North Am. 1999 Jun;13(2):285-97, vii. doi: 10.1016/s0891-5520(05)70075-1.